中国医科大学学报
中國醫科大學學報
중국의과대학학보
Journal of China Medical University
2015年
10期
865-869
,共5页
李尔然%姜艳霞%王昆%李艳玲%康健
李爾然%薑豔霞%王昆%李豔玲%康健
리이연%강염하%왕곤%리염령%강건
血清半乳甘露聚糖检测%侵袭性肺曲霉病
血清半乳甘露聚糖檢測%侵襲性肺麯黴病
혈청반유감로취당검측%침습성폐곡매병
galactomannan%invasive pulmonary aspergillosis
目的:探讨血清半乳甘露聚糖(GM)试验在侵袭性肺曲霉病(IPA)中的临床诊断价值。方法收集2010年3月至2011年3月期间中国医科大学附属第一医院及周边5所医院住院IPA高危患者共计103例,男60例(58.3%),女43例(41.7%),中位年龄51.90岁(18~86岁)。应用双夹心酶联免疫吸附法(ELISA)对疑诊患者的血清GM进行检测。结果所有入选患者中,确定诊断7例(6.8%),临床诊断19例(18.4%),拟诊40例(38.8%),排除IPA感染37例(36%)。以血清GM值单次>0.5为本次研究的界值,其敏感度、特异度、阳性预测值及阴性预测值分别为85.7%、86.5%、55%及97%,与拟诊组相比,GM检测对确诊组有更好的临床符合度。将入选患者分为粒缺组与非粒缺组时,GM检测的敏感性分别为74%与42%,在非粒缺患者中,GM试验对慢性肺部基础疾病并发IPA的诊断敏感性、特异性、阳性预测值及阴性预测值分别为71.4%、84.4%、66.75%及87.1%。以GM值0.5作为阳性界值,对可疑IPA患者给予抗曲霉菌治疗。与对照组相比,随着诊断级别的提高,拟诊组、临床诊断组及确诊组抗真菌治疗有效率逐渐降低,分别为70%、56%、40%。结论以GM值0.5作为阳性界值对IPA诊断有着良好的敏感性及特异性。GM试验在非粒缺合并慢性肺基础疾病的患者中诊断价值较高。GM试验与影像学检查、体液培养等传统检测方法相比,具有更高的敏感性及特异性,联合诊断能够提高IPA的临床诊断率。
目的:探討血清半乳甘露聚糖(GM)試驗在侵襲性肺麯黴病(IPA)中的臨床診斷價值。方法收集2010年3月至2011年3月期間中國醫科大學附屬第一醫院及週邊5所醫院住院IPA高危患者共計103例,男60例(58.3%),女43例(41.7%),中位年齡51.90歲(18~86歲)。應用雙夾心酶聯免疫吸附法(ELISA)對疑診患者的血清GM進行檢測。結果所有入選患者中,確定診斷7例(6.8%),臨床診斷19例(18.4%),擬診40例(38.8%),排除IPA感染37例(36%)。以血清GM值單次>0.5為本次研究的界值,其敏感度、特異度、暘性預測值及陰性預測值分彆為85.7%、86.5%、55%及97%,與擬診組相比,GM檢測對確診組有更好的臨床符閤度。將入選患者分為粒缺組與非粒缺組時,GM檢測的敏感性分彆為74%與42%,在非粒缺患者中,GM試驗對慢性肺部基礎疾病併髮IPA的診斷敏感性、特異性、暘性預測值及陰性預測值分彆為71.4%、84.4%、66.75%及87.1%。以GM值0.5作為暘性界值,對可疑IPA患者給予抗麯黴菌治療。與對照組相比,隨著診斷級彆的提高,擬診組、臨床診斷組及確診組抗真菌治療有效率逐漸降低,分彆為70%、56%、40%。結論以GM值0.5作為暘性界值對IPA診斷有著良好的敏感性及特異性。GM試驗在非粒缺閤併慢性肺基礎疾病的患者中診斷價值較高。GM試驗與影像學檢查、體液培養等傳統檢測方法相比,具有更高的敏感性及特異性,聯閤診斷能夠提高IPA的臨床診斷率。
목적:탐토혈청반유감로취당(GM)시험재침습성폐곡매병(IPA)중적림상진단개치。방법수집2010년3월지2011년3월기간중국의과대학부속제일의원급주변5소의원주원IPA고위환자공계103례,남60례(58.3%),녀43례(41.7%),중위년령51.90세(18~86세)。응용쌍협심매련면역흡부법(ELISA)대의진환자적혈청GM진행검측。결과소유입선환자중,학정진단7례(6.8%),림상진단19례(18.4%),의진40례(38.8%),배제IPA감염37례(36%)。이혈청GM치단차>0.5위본차연구적계치,기민감도、특이도、양성예측치급음성예측치분별위85.7%、86.5%、55%급97%,여의진조상비,GM검측대학진조유경호적림상부합도。장입선환자분위립결조여비립결조시,GM검측적민감성분별위74%여42%,재비립결환자중,GM시험대만성폐부기출질병병발IPA적진단민감성、특이성、양성예측치급음성예측치분별위71.4%、84.4%、66.75%급87.1%。이GM치0.5작위양성계치,대가의IPA환자급여항곡매균치료。여대조조상비,수착진단급별적제고,의진조、림상진단조급학진조항진균치료유효솔축점강저,분별위70%、56%、40%。결론이GM치0.5작위양성계치대IPA진단유착량호적민감성급특이성。GM시험재비립결합병만성폐기출질병적환자중진단개치교고。GM시험여영상학검사、체액배양등전통검측방법상비,구유경고적민감성급특이성,연합진단능구제고IPA적림상진단솔。
Objective To evaluate the value of serum galactomannan (GM) detection for invasive pulmonary aspergillosis (IPA) diagnosis. Methods The suspicious IPA patients were divided into proven,clinical and possible IPA groups. The patients excluded of IPA were recruited as controls. The serum GM concentration was detected by Platelia Aspergillus double?sandwich enzyme linked immunosorbent assay(ELISA). Re?sults In the 103 patients,there were seven cases diagnosed as proven,nineteen cases diagnosed as clinical and forty cases diagnosed as possible IPA patients. Setting 0.5 as the optimal result for GM detection,the sensitivity,specificity,positive predictive values and negative predictive values of GM were 85.7%,86.5%,55%and 97%,respectively. In non?neutropenia patients combinded with the pulmonary chronic diseases,the sensitivity, specificity,positive predictive values and negative predictive values of GM detection were 71.4%,84.4%,66.75%and 87.1%,respectively. Conclu?sion Index>0.5 for GM test could increase the sensitivity without obvious decreased specificity. GM detection could provide valuable information in patients of non?neutropenia underlying the pulmonary chronic diseases,which had a better sensitivity and specificity versus conventional diagnostic tests.